Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gain Therapeutics (GANX) Tax Rate (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Tax Rate data on record, last reported at 11.6% in Q3 2025.

  • For Q3 2025, Tax Rate fell 1135.0% year-over-year to 11.6%; the TTM value through Sep 2025 reached 7.16%, down 694.0%, while the annual FY2024 figure was 2.7%, 235.0% down from the prior year.
  • Tax Rate reached 11.6% in Q3 2025 per GANX's latest filing, down from 2.49% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.61% in Q4 2022 and bottomed at 15.47% in Q4 2024.
  • Average Tax Rate over 5 years is 1.8%, with a median of 0.25% recorded in 2024.
  • Peak YoY movement for Tax Rate: soared 80bps in 2022, then plummeted -1518bps in 2024.
  • A 5-year view of Tax Rate shows it stood at 0.19% in 2021, then surged by 425bps to 0.61% in 2022, then tumbled by -147bps to 0.29% in 2023, then plummeted by -5231bps to 15.47% in 2024, then increased by 25bps to 11.6% in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Rate were 11.6% in Q3 2025, 2.49% in Q2 2025, and 2.27% in Q1 2025.